Overview

Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Status:
Terminated

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the long-term safety of botulinum toxin type A for the treatment of moderate to severe crow's feet lines after repeat application.

Phase:

Phase 3

Details

Lead Sponsor:

Revance Therapeutics, Inc.

Treatments:

abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA